Sadan Soyyiğit

Summary

Publications

  1. doi request reprint Evaluation of drug provocation test-related anxiety in patients with drug hypersensitivity
    Sadan Soyyiğit
    Division of Immunology and Allergy, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey Electronic address
    Ann Allergy Asthma Immunol 117:280-4. 2016
  2. ncbi request reprint [The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease]
    Sadan Soyyiğit
    Department of Chest Disease, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Tuberk Toraks 54:259-66. 2006
  3. doi request reprint Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases
    Omur Aydin
    Division of Immunology and Allergy, Department of Chest Disease, Ankara University School of Medicine, Ankara, Turkey
    Allergy Asthma Proc 36:493-500. 2015
  4. doi request reprint Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients
    Sadan Soyyiğit
    Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University, School of Medicine, Ankara, Turkey
    Ann Allergy Asthma Immunol 116:244-251.e2. 2016
  5. doi request reprint Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients
    Insu Yilmaz
    Department of Chest Diseases, Division of Immunology and Allergy, Ankara University School of Medicine, Ankara, Turkey
    Clin Respir J 9:350-8. 2015
  6. doi request reprint Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics
    Sevim Bavbek
    Division of Immunology and Allergy, Department of Chest Diseases, School of Medicine, Ankara University, Ankara, Turkey
    Int Arch Allergy Immunol 171:227-233. 2017
  7. ncbi request reprint A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study
    Tülin Kuyucu
    Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey
    Tuberk Toraks 59:328-39. 2011

Collaborators

  • Omur Aydin
  • Betül Ayse Sin
  • Gülfem Celik
  • Zeynep Celebi Sözener
  • Sevket Ozkaya
  • Sevim Bavbek
  • Insu Yilmaz
  • Tülin Kuyucu
  • Resat Kendirlinan
  • Reyhan Gümüşburun
  • Pamir Çerçi
  • Seda Altıner
  • Zeynep Sözener
  • Dilsad Mungan
  • Zeynep Misirligil
  • Cetin Atasoy
  • Nursen Duzgun
  • Seçil Kepil Ozdemir
  • Selcan Özgüçlü
  • Yavuz Selim Demirel
  • Ferit Ozen
  • Salih Zeki Guclu
  • Bengü Büyükgöze
  • Hüseyin Akkurt
  • Salim Seyfettin
  • Gökhan Asal
  • Merve Gülcan Bayrak
  • Zeki Cangül
  • Ozhan Kula
  • Bengü Saylan
  • Tuncay Güler
  • Taha Tahir Bekçi
  • Ejder Koyuncu
  • Osman Oztürk
  • Cahit Demir
  • Tuncer Senol
  • Sezai Oztürk
  • Serdar Güner
  • Sevilay Ciçek Ocak
  • Makbule Ozlem Akbay
  • Yavuz Selim Intepe
  • Seyma Başlılar
  • Semih Ağanoğlu

Detail Information

Publications7

  1. doi request reprint Evaluation of drug provocation test-related anxiety in patients with drug hypersensitivity
    Sadan Soyyiğit
    Division of Immunology and Allergy, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey Electronic address
    Ann Allergy Asthma Immunol 117:280-4. 2016
    ..Drug provocation tests (DPTs) are important in the treatment of patients with drug hypersensitivity (DH), but they carry certain hypersensitivity reaction risks, which lead to procedure-related concerns in patients...
  2. ncbi request reprint [The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease]
    Sadan Soyyiğit
    Department of Chest Disease, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Tuberk Toraks 54:259-66. 2006
    ..51, r = 0.53, r = -0.61, r = 0.64 respectively). The SF-36 general quality of life questionnaire is a useful measurement instrument for the evaluation of therapeutic efficiency and follow up of COPD patients...
  3. doi request reprint Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases
    Omur Aydin
    Division of Immunology and Allergy, Department of Chest Disease, Ankara University School of Medicine, Ankara, Turkey
    Allergy Asthma Proc 36:493-500. 2015
    ..Omalizumab has been a valuable option for patients with severe allergic asthma, but there are only case reports regarding effectiveness of omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA)...
  4. doi request reprint Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients
    Sadan Soyyiğit
    Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University, School of Medicine, Ankara, Turkey
    Ann Allergy Asthma Immunol 116:244-251.e2. 2016
    ..There is a continuing debate about whether monoallergen subcutaneous immunotherapy (SCIT) is able to modulate immune and clinical responses toward main causal allergen in polysensitized patients...
  5. doi request reprint Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients
    Insu Yilmaz
    Department of Chest Diseases, Division of Immunology and Allergy, Ankara University School of Medicine, Ankara, Turkey
    Clin Respir J 9:350-8. 2015
    ..Churg-Strauss syndrome (CSS) is a rare multisystem vasculitis. Considering the variation of autoimmune diseases in different races, it is of interest to determine whether any outstanding features exist for Turkish patients with CSS...
  6. doi request reprint Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics
    Sevim Bavbek
    Division of Immunology and Allergy, Department of Chest Diseases, School of Medicine, Ankara University, Ankara, Turkey
    Int Arch Allergy Immunol 171:227-233. 2017
    ..Data are limited regarding the use of RDD outside the USA. Our purpose was to report our data on RDD to rituximab, infliximab, cetuximab, and trastuzumab...
  7. ncbi request reprint A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study
    Tülin Kuyucu
    Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey
    Tuberk Toraks 59:328-39. 2011
    ....